Sort by
Refine Your Search
-
with a PhD in Engineering (or close to completion) may apply. You will be responsible for: Design of the first reconfigurable robotic matter in collaboration with world-leading universities and
-
amino acids and growth factors. You will hold a PhD/D.Phil. or be near completion* in microbiology, molecular biology, cell biology or closely related area together with relevant experience and have
-
generate key structural and biophysical data to support the design of small molecule inhibitors with particular focus on protein production and crystallisation, solving protein-ligand structures, fragment
-
into disease progression, with the ultimate aim of identifying novel biomarkers and therapeutic targets. You will hold a relevant PhD/DPhil, together with sufficient specialist knowledge in normal and malignant
-
essential that you hold a PhD/DPhil (or close to completion) in mathematics, computational biology, data science, statistics, physics, or a related discipline, and have experience of analysing and
-
of the research group, including postdocs, research assistants, technicians, PhD and project students, as well as to represent the PI and ISML when required. You will hold a Masters or PhD degree (or be close to
-
of agentic behaviour and publishing high-impact research. Candidates should possess a PhD (or be near completion) in PhD in Computer Science, AI, Security, or a related field. You will have a Strong background
-
facilely applied as a photoluminescent layer, targeting in situ detection and non-contact visualization of surface temperatures and pressures. You should hold a PhD/DPhil (or near completion*) in materials
-
to underfill at Grade 6 (£34,982 - £40,855 p.a.) if candidate holds a relevant degree and is working on PhD/DPhil) together with established knowledge in computer architecture and hardware security, significant
-
and how it may respond to vaccination. You will supervise master’s and PhD students, and support the overall efforts of the lab. This post offers the opportunity to engage in cutting-edge translational